Cedars-Sinai Team Pioneers Liver Cancer Blood Test
Cedars-Sinai Cancer investigators have created a blood test that uses a technology to detect the most common form of liver cancer.
Read MorePosted by Andy Lundin | Sep 1, 2022 | Unknown Origin & Other Cancer Types |
Cedars-Sinai Cancer investigators have created a blood test that uses a technology to detect the most common form of liver cancer.
Read MorePosted by Andy Lundin | Aug 30, 2022 | Womens Health |
In many parts of the U.S., broad genetic testing is offered to prospective parents and is usually also recommended in early pregnancy.
Read MorePosted by Andy Lundin | Aug 30, 2022 | Covid 19 |
Cue Health announced the nationwide launch of Cue Care, its same-day, at-home, test-to-treatment solution.
Read MorePosted by Andy Lundin | Aug 25, 2022 | Gastrointestinal Infections |
The new test helps physicians monitor inflammation of the gastrointestinal tract by painlessly collecting samples while the patient is awake.
Read MorePosted by Chris Wolski | Aug 23, 2022 | Unknown Origin & Other Cancer Types |
A new research paper “Using quantitative immunohistochemistry in patients at high risk for hepatocellular cancer” was published.
Read More